Steroid-Releasing Sinus Implant Deemed Effective, Safe

Share this content:
Steroid-Releasing Sinus Implant Deemed Effective, Safe
Steroid-Releasing Sinus Implant Deemed Effective, Safe

MONDAY, Nov. 6, 2017 (HealthDay News) -- For patients with chronic rhinosinusitis (CRS), placement of an hourglass-shaped bioabsorbable, steroid-releasing sinus implant improves postoperative outcomes when placed in the frontal sinus ostia (FSO) after endoscopic sinus surgery (ESS), according to a study published online Nov. 2 in JAMA Otolaryngology -- Head & Neck Surgery.

Amber Luong, M.D., Ph.D., from McGovern Medical School at the University of Texas Health Science Center in Houston, and colleagues conducted a randomized clinical trial using an intrapatient control design to examine the safety and efficacy of the hourglass-shaped bioabsorbable, steroid-releasing sinus implant. Eighty adult patients with CRS were enrolled and underwent bilateral frontal sinusotomies with one FSO randomized to receive a steroid-releasing implant.

The researchers found that steroid-releasing implants significantly reduced the need for postoperative interventions to 11.5 percent compared with 32.8 percent by surgery alone at day 30 (mean difference, −21.3 percent). In real-time endoscopic assessment, compared with the control side, the treated side had a significant reduction in the need for postoperative intervention, a significant reduction in inflammation score, and a significant reduction in the rate of frontal restenosis or occlusion at day 30. The results favoring the treated side were sustained through day 90. There were no adverse events related to implants.

"The hourglass-shaped steroid-releasing sinus implant was safe and more effective in maintaining FSO patency and improving surgical outcomes compared with surgery alone," the authors write.

Several authors disclosed ties to the medical technology industry, including Intersect ENT, which provided funding for the study.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »